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Abstract
Background: Small-diameter, myelinated axons are selectively susceptible to dysfunction in several inflammatory
PNS and CNS diseases, resulting in pain and degeneration, but the mechanism is not known.
Methods: We used in vivo confocal microscopy to compare the effects of inflammation in experimental autoimmune
neuritis (EAN), a model of Guillain-Barré syndrome (GBS), on mitochondrial function and transport in large- and small-
diameter axons. We have compared mitochondrial function and transport in vivo in (i) healthy axons, (ii) axons affected
by experimental autoimmune neuritis, and (iii) axons in which mitochondria were focally damaged by laser induced
photo-toxicity.
Results: Mitochondria affected by inflammation or laser damage became depolarized, fragmented, and immobile.
Importantly, the loss of functional mitochondria was accompanied by an increase in the number of mitochondria
transported towards, and into, the damaged area, perhaps compensating for loss of ATP and allowing buffering of the
likely excessive Ca2+ concentration. In large-diameter axons, healthy mitochondria were found to move into the
damaged area bypassing the dysfunctional mitochondria, re-populating the damaged segment of the axon.
However, in small-diameter axons, the depolarized mitochondria appeared to “plug” the axon, obstructing,
sometimes completely, the incoming (mainly anterograde) transport of mitochondria. Over time (~ 2 h), the
transported, functional mitochondria accumulated at the obstruction, and the distal part of the small-diameter
axons became depleted of functional mitochondria.
Conclusions: The data show that neuroinflammation, in common with photo-toxic damage, induces depolarization
and fragmentation of axonal mitochondria, which remain immobile at the site of damage. The damaged, immobile
mitochondria can “plug” myelinated, small-diameter axons so that successful mitochondrial transport is prevented,
depleting the distal axon of functioning mitochondria. Our observations may explain the selective vulnerability of small-
diameter axons to dysfunction and degeneration in a number of neurodegenerative and neuroinflammatory disorders.
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Background
Guillain-Barré syndrome (GBS) is a life-threatening, typ-
ically post-infectious, immune-mediated disease of the
peripheral nervous system. Severe ascending muscle
weakness, caused by dysfunction of peripheral motor
fibers, is the best recognized and the most dramatic sign
of the disease. Although most patients survive, about
half retain a residual neurological deficit, which can be
severe [1]. Sensory symptoms have been under-
emphasized [2], but recent studies reveal that these are
clinically relevant [3–5] and prevalent, with paresthesia
being reported by 75% [2] of patients and pain by 89%
[6]. Interestingly, these symptoms often precede muscle
weakness. The presence of pain, paresthesia, and abnor-
mal thresholds for thermal and mechanical stimuli [7]
can occur several weeks prior to muscle weakness [8, 9].
Furthermore, following recovery, sensory impairment re-
mains a long-term consequence of GBS, substantially
impairing the quality of life [1, 10, 11]. Indeed, a pro-
spective multi-center study conducted 2 years after dis-
ease onset identified sensory impairment in over half of
the patient population [11], while another study reported
that sensory deficits persist in the legs of 66% of patients
between 3 and 6 years after the onset of GBS [12].
The early presence of sensory signs and symptoms and
the long-term deficit suggest that small-caliber myelin-
ated (Aδ) and unmyelinated axons (C fibers) are affected
early in the pathogenesis of GBS. Indeed, the temporal
pattern of functional impairment of these axons suggests
that they are more vulnerable to inflammatory damage
than the larger, motor axons. However, the pathophysio-
logical mechanisms underlying the preferential vulner-
ability of small-diameter axons are unknown.
We have used confocal microscopy to compare the
effects of experimental autoimmune neuritis (EAN), a
model of GBS, on mitochondrial function and transport in
myelinated, large-, and small-diameter axons in vivo at the
time of onset of neurological deficits. We found that mito-
chondria depolarized, fragmented, and stopped trafficking
early in the disease in all axons, but in small axons alone,
the damaged mitochondria obstructed normal axonal
transport of functional mitochondria, causing depletion of
mitochondria distal to the site of damage. Mitochondrial
blockage of myelinated, small-diameter axons may con-
tribute to other disorders characterized by preferential
degeneration of small fibers, including diabetic and
chemotherapy-induced neuropathies.
Results
Inflammation at the onset of EAN reduces the number of
transported mitochondria in peripheral nerve axons, but
not their velocity
To investigate the mechanisms of inflammatory damage
to peripheral nerve axons and axonal mitochondria, we
immunized mito-S CFP+ mice with peripheral nerve
myelin, and Mycobacterium tuberculosis and pertussis
toxin as adjuvants. Such immunization results in an
autoimmune response against proteins of peripheral
nerve myelin in which spinal roots and peripheral nerves
are infiltrated by inflammatory cells. EAN manifests first
caudally, typically with temporary hind limb and tail
weakness or paralysis, ascending rostrally, as occurs in
GBS. To study the early pathological events in EAN, we
imaged mitochondria in saphenous nerve axons at the
first indication of clinical disease expression, typically
weight loss and weakness of the tip of the tail. At this
time, the vast majority of axons showed normal morph-
ology, indistinguishable from that in time-matched
asymptomatic controls and adjuvant controls. However,
only in animals with EAN, we observed that the saphe-
nous nerves contained a number of infiltrating cells with
the characteristics typical of amoeboid macrophages, in-
cluding the binding of isolectin B4 (IB4) (green fluores-
cent label). Also, time-lapse imaging revealed that these
cells moved between individual fibers (Additional files 1
and 2: Videos S1 and S2). Interestingly, in some thin
axons in the vicinity of the infiltrating cells, the distribu-
tion of mitochondria was uneven, with mitochondria in
clumps instead of the typically uniform distribution of
mitochondria seen in normal axons. Indeed, neither in-
filtrating cells nor clumps of mitochondria were found
in control animals.
We wondered if the clumping of mitochondria may
indicate a defect in mitochondrial transport, so we mea-
sured this in animals with EAN at disease onset, i.e.,
mild weakness of tail tip, comparing the findings with
transport in immunized but asymptomatic animals
(asymptomatic EAN), and in control animals that re-
ceived adjuvant only (adjuvant controls). Control ani-
mals were examined on the same day as their cohort
symptomatic animal or the next day. We found no dif-
ferences between the number of transported mitochon-
dria in adjuvant controls and asymptomatic EAN
animals, in either the anterograde (towards the periph-
eral terminal) or the retrograde (towards the dorsal root
ganglion (DRG)) directions. The median number of
anterogradely transported mitochondria in adjuvant con-
trols and asymptomatic mice with EAN was 14 (inter-
quartile range (IQR) = 8–22) and 16 (IQR = 9–22),
respectively, with the median number of retrogradely
transported mitochondria in the two types of control
equal to 3 (IQR = 2–7) and 4 (2–6) respectively. However,
in animals expressing a neurological deficit, the median
number of anterogradely transported mitochondria was
reduced by more than half to 6 (2–14.5) in comparison
with control groups (Fig. 1a, p< 0.001, non-parametric
one-way ANOVA, Dunn’s post-test). The number of
retrogradely transported mitochondria [(1 (0–3)) was also
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Fig. 1 First signs of EAN are associated with inflammatory infiltration within the saphenous nerve. a Low-power image of dissected saphenous
nerve, labeled in situ with TMRM (red) and IB4 (green), showing the outlines of nerve fibers and the connective tissues surrounding them. b
High-power image of nerve fibers within the saphenous nerve in an adjuvant control animal, showing one IB4+ C fiber (green) and a number of
elongated, polarized axonal mitochondria (red). c High-power image of nerve fibers within the saphenous nerve in a symptomatic animal on the
first day of onset of EAN, showing a number of infiltrating inflammatory cells labeled with IB4+ (green arrows), within which mitochondria labeled
with TMRM can be seen. In one axon (white arrowhead), polarized axonal mitochondria appear focally accumulated, as opposed to uniformly
distributed mitochondrial in surrounding fibers. One of the inflammatory cells (dashed yellow arrow) can be seen juxtaposed to this focal accumulation
(see also Additional file 1: Video S1, encircled). d, d′ After 40 min, the same inflammatory cell (dashed yellow arrow) is present at the
same location (see also Additional file 2: Video S2). d′ The focal accumulation of axonal mitochondria shown from a different optical plane in order to
visualize the mitochondria in the inset (see also Additional file 2: Video S2). This accumulation of mitochondria appears to have increased in
comparison with the earlier time point (c). e In the symptomatic phase of EAN (n = 101 axons; 3 animals), the number of both anterogra-
dely and retrogradely moving mitochondria in normal appearing axons was significantly decreased in comparison with adjuvant-only (n =
133 axons; 6 animals) and asymptomatic EAN animals (n = 44 axons; 3 animals) (***p < 0.001, two-way ANOVA). The systemic injection of LPS did not
significantly change the number of transported mitochondria in comparison with asymptomatic EAN or adjuvant control animals and remained signifi-
cantly higher than the number of anterogradely moving mitochondria in symptomatic EAN animals (***p< 0.001, two-way ANOVA). Similarly, incubation
in vivo of saphenous nerve axons with macrophages activated ex vivo did not significantly change the number of moving mitochondria in comparison
with controls, although the number of transported mitochondria in both directions in these animals tended to be lower than in controls and animals with
systemic LPS. f The average speed of moving mitochondria was not affected by either of the studied conditions (p> 0.05, two-way ANOVA)
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significantly lower than in control groups (p < 0.001, non-
parametric one-way ANOVA, Dunn’s post-test). There-
fore, at the onset of disease expression, the observations
reveal infiltrating inflammatory cells within the perineur-
ium and a significant reduction in axonal mitochondrial
transport. Interestingly, the overall axonal structure in
these fibers appeared normal, and the mitochondrial dis-
tribution was unaffected despite the reduction in axonal
mitochondrial transport.
As the systemic inflammation alone (adjuvant controls)
did not alter mitochondrial transport, we postulated that
the infiltrating population of inflammatory cells may be
responsible for the observed result. To determine whether
the presence of inflammatory cells in the vicinity of axons
may cause impairment of mitochondrial transport within
those axons, we examined mitochondrial axonal transport
in two different experimental paradigms. First, to exclude
the possibility that systemic inflammation affects mito-
chondrial transport, we induced systemic inflammation by
an intraperitoneal injection of lipopolysaccharide (LPS).
Two to 4 h after LPS injection, when animals exhibit sick-
ness behavior (i.e., reduced activity, piloerection, hyper-
ventilation), we measured mitochondrial transport in
saphenous nerve axons. The number of transported mito-
chondria was similar to that in adjuvant controls and
asymptomatic EAN animals, and anterograde and retro-
grade transport was similar to controls (median antero-
grade and retrograde transport (±IQR) = 12 (5–17) and 2
(1–6) respectively (Fig. 1a). We then examined whether
the presence of inflammatory cells infiltrated amongst the
axons impaired mitochondrial transport, as seen at the
onset of EAN. We mimicked inflammation in the periph-
eral nerve by incubating the saphenous nerve axons with
activated macrophages. For this purpose, we isolated peri-
toneal macrophages from naïve mice and incubated them
overnight with sciatic nerve excised from another C57BL6
mouse, in the presence of LPS. On the next day, we
opened the perineurium of saphenous nerve axons in vivo
and exposed them to 500,000 of these activated macro-
phages which were re-suspended in 200 μl of supernatant.
We measured axonal transport 1 h after adding the mac-
rophages to exposed axons. In comparison with adjuvant
control and asymptomatic mice, this “applied infiltration”
of saphenous nerve by activated macrophages reduced the
number of mitochondria moving both anterogradely [me-
dian (IQR) = 11 (8–17.5)] and retrogradely [median
(IQR) = 2 (1–4)], although this reduction did not
reach statistical significance (Fig. 1e) in comparison with
either adjuvant control or asymptomatic animals.
We investigated whether the decrease in the number
of transported mitochondria was a result of a reduced
speed of mitochondria, but we found no differences
in transport speed in either direction between the
groups (Fig. 1f ).
Inflammation during the symptomatic phase of EAN is
associated with mitochondrial fragmentation, loss of
mitochondrial membrane potential, and focal
accumulations of damaged mitochondria
Examination of the length of axonal mitochondria re-
vealed that stationary mitochondria at the onset of EAN
were marginally shorter (2.6 ± 1.2 μm) than mitochon-
dria in axons from animals with asymptomatic EAN
(2.7 ± 1.3 μm; p < 0.01, one-way ANOVA, Dunns’ post-
test), but significantly shorter than mitochondria in adju-
vant controls (3 ± 1.5 μm, p < 0.001) (Fig. 2a). This
finding indicates that immunization with peripheral
nerve antigens may tilt the mitochondrial fusion/fission
balance in favor of fission, even when signs of the dis-
ease are undetectable or barely detectable. As increased
mitochondrial fission has been associated with mito-
chondrial dysfunction in neurodegenerative diseases
[13–15], we next examined whether axonal mitochon-
dria maintained their mitochondrial membrane potential
(Fig. 2a–b′). Using transgenic mice that constitutively
express cyan fluorescent protein in axonal mitochondria
independently of mitochondrial membrane potential
(i.e., both functional and dysfunctional axonal mitochon-
dria appear blue), we applied the potentiometric dye
TMRM (red) to the axons to distinguish functional
(positive for CFP with accumulated TMRM, appearing
pink or white) from dysfunctional mitochondria (positive
for CFP but failing to accumulate TMRM, appearing
blue) in vivo. In healthy controls and asymptomatic ani-
mals, the vast majority of axons were characterized by
mitochondria of various lengths, amongst which both
elongated and round shorter mitochondria were clearly
labeled with both CFP and TMRM (Fig. 2d, white ar-
rows). However, in animals with EAN, about 10% of
axons showed an atypical, focal accumulation of mito-
chondria (Fig. 2b–e, arrows), and within these accumula-
tions, depolarized mitochondria (blue) were stationary
throughout the period of observation (typically over
2 h). Also, the depolarized mitochondria were fragmen-
ted, typical of damaged mitochondria [16]. Indeed, given
that the fragmented and depolarized mitochondria do
not participate in mitochondrial fusion, this effect of
inflammation may have contributed to the perceived
shortening of axonal mitochondria mentioned above.
Interestingly, the focal accumulations, consisting of a mix-
ture of depolarized and polarized mitochondria, appeared
gradually to increase in size (Fig. 2b and b′). Furthermore,
time-lapse imaging revealed that the accumulations oc-
curred predominantly, although not exclusively, by antero-
gradely moving, polarized, mitochondria joining the “road
block” (Additional files 3 and 4: Videos S3 and S4). Inter-
estingly, only small-diameter myelinated axons seemed to
be affected by mitochondrial accumulations (Fig. 2a′). We
then measured the mitochondrial density in axons of
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different calibers and found that, indeed, small-caliber
axons tend to host a greater density of mitochondria than
large-caliber axons (Fig. 2c, p< 0.0001, r2 = 0.16). The
combination of small-diameter and greater mitochon-
drial density makes small-diameter axons especially
vulnerable to plugging when mitochondria are dam-
aged and transport ceases.
Focal mitochondrial damage increases anterograde
mitochondrial transport into the damaged area but
causes accumulations of mitochondria in small-diameter
fibers
We postulated that damaged mitochondria might cause
a road block in the path of incoming transported axonal
mitochondria. To test this hypothesis, we induced
localized mitochondrial damage by photo-toxic bleach-
ing (561 nm) in a well-defined area (Fig. 3, 124 × 124 μm
region in A), and measured mitochondrial transport dis-
tally and proximally to the bleached region, before and
shortly after damage (Fig. 3, regions 1 and 5 in B). We
found that distal to the site of photo-toxic mitochondrial
damage, the number of anterogradely and retrogradely
moving mitochondria did not significantly change
(Fig. 3d). However, proximal to the damage, there was a
clear increase in anterograde transport in all examined
axons (Fig. 3c, p = 0.008, repeated measures ANOVA).
Thus, the damaged region of the axons seems repopu-
lated mainly by the increase in number of anterogradely
trafficking mitochondria moving into the region. The
preponderance of anterogradely moving mitochondria
Fig. 2 Inflammatory infiltration within peripheral nerve during EAN is associated with changes in mitochondrial distribution and axonal transport of
mitochondria. a Polarized stationary mitochondria in axons of animals with either symptomatic or asymptomatic EAN are significantly shorter than in
adjuvant controls (p< 0.0001, one-way ANOVA). a′ Focal accumulations of mitochondria are found primarily in small-diameter (mean ± SD= 3.34 ±
0.61 μm) axons; there was statistically significant difference between the total number of axons with detected accumulations found in adjuvant control
(n= 6 animals) vs. EAN (n= 3 animals) groups (p< 0.001, Student’s t test. b The symptomatic phase of EAN is associated with focal accumulations of
mitochondria (thin arrows), and these accumulate further over time (e.g., after 1 h, shown in b′, thick arrows), primarily by the addition of anterogradely
trafficking healthy mitochondria, as observed by time-lapse imaging, in vivo. c In control axons, the density of polarized mitochondria
tends to decrease with increasing caliber of axons (p< 0.0001, r2 = 0.16, Pearson correlation) indicating space restrictions for axonal mitochondrial transport
in small-diameter axons. d–e″ Healthy axonal mitochondria are electrically polarized (i.e., they fluoresce red, TMRM+), appearing pale/white (white arrows)
when they overlap with the blue fluorescence of CFP+ mitochondria. In animals with symptomatic EAN, some mitochondria become fragmented (short
and round) but retain membrane potential (green arrows) whereas other mitochondria appear clearly damaged, not only appearing small and
round, but also depolarized (TMRM−, blue arrows). Such mitochondria appear immobile, remaining stationary at the site of damage for at least 1 h
(blue arrows). Healthy mitochondria join the accumulations (red arrows) but appear to become trapped at the site of damage
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into the photo-bleached region can be observed in
time-lapse images of the region obtained within a few
minutes after the photo-toxic depletion of mitochon-
dria (Additional file 5: Video S5).
Within the region subjected to photo-bleaching, all
the mitochondria initially appeared polarized and uni-
formly distributed along the axons (Fig. 4a), but then, as
expected following photo-bleaching, they all promptly
became depolarized (TMRM−, Fig. 4b). The majority of
the mitochondria retained their original shape and size,
but some mitochondrial fragmentation occurred, includ-
ing the formation of a small number of short, round
mitochondria typical of the damaged form [16] (Fig. 4,
blue arrows in B). Over the following hours, the vast
majority of mitochondria within the photo-bleached area
underwent fragmentation. These CFP+ TMRM− mito-
chondrial fragments remained stationary for at least
2.5 h (Fig. 4, blue arrows in C, D, and E). As mentioned
above, the photo-bleaching induced an increase in an-
terograde mitochondrial transport, and these polarized,
anterogradely transported mitochondria began to re-
populate the damaged region. However, the passage of
the healthy, polarized mitochondria towards the distal
parts of the axons was hindered by the stationary frag-
ments of mitochondria generated by the photo-bleaching,
resulting in the formation of focal mitochondrial
Fig. 3 Depletion of functional mitochondria from the photo-bleached segment of axons induces a compensatory increase in anterograde mitochondrial
transport proximal to the bleached site. a Tile image of saphenous nerve prior to photo-bleaching labeled with TMRM (red; healthy mitochondria) and IB4
(green; IB4+ C fibers, connective tissue); area exposed to the photo-bleaching is outlined in white. b Tile image of saphenous nerve immediately after the
photo-bleaching, labeled with TMRM and IB4. Axons traversing the photo-bleached area and areas proximal (region 1 outlined in yellow) and distal (region
5 outlined in yellow) to the photo-bleached area were used for measurements of mitochondrial transport before and after the photo-bleach. c In axons
proximal to the photo-bleached area, the number of transported mitochondria was measured before and after photo-bleach. The number of anterogradely
moving mitochondria was significantly greater (**p= 0.008, repeated measures ANOVA; n= 8) after the photo-bleach than before the photo-bleach,
whereas there were no differences in numbers of mitochondria moving retrogradely before and after the photo-bleach. d In axons distal
to the photo-bleached area, there were no statistically significant differences in the numbers of mitochondria moving in direction either
before or after the photo-bleach (p > 0.05, repeated measures ANOVA, n = 12)
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accumulations consisting of both polarized and depolar-
ized mitochondria (Fig. 4, white arrows in D). These accu-
mulations steadily increased in size, mainly growing in the
proximal direction (Fig. 4, white arrowheads in E), while
the distal parts of the axons became depleted of
mitochondria. Interestingly, accumulations of mitochon-
dria only occurred in small-diameter, myelinated, fibers
measuring 3.02 (± 0.7) μm (mean ± SD, n = 18 axons from
three separate experiments). In larger axons, measuring
4.24 (± 1.15) μm (mean ± SD, n = 35 axons from three
Fig. 4 Mitochondria damaged by photo-bleaching remain at the site of damage obstructing the passage of cargoes along the small-diameter axons,
resulting in a selective block of transport in small-diameter fibers. Before the photo-bleaching (a), axonal mitochondria appear healthy or electrically
polarized (i.e., they fluoresce red, TMRM+), appearing pale/white when they overlap with the blue fluorescence of CFP+ mitochondria. Photo-bleaching
induces fragmentation and damage of mitochondria (blue arrows, b–d) which remain at the site of damage for over 2 h (e). Depletion of functional
mitochondria from the photo-bleached segment of axons induces a compensatory increase in anterograde mitochondrial transport proximal to
the bleached site, resulting in re-population of these segments with healthy (TMRM+; red arrows, c–e) mitochondria. This mechanism successfully
replenishes the mitochondria in axons of large and medium diameter (white asterisks, a, e). However, in small axons, the damaged mitochondria
appear to block the passage of healthy mitochondria, resulting in proximal mitochondrial accumulations (white arrows in d, white arrowheads in e),
and paucity of healthy mitochondria distal to the transport block—note the lack of TMRM+ mitochondria distal to white arrows, while CFP+ mitochondria
remain stationary. Average diameter (±SD) of the fibers with mitochondrial transport block 2.5 h after bleaching was 3.02 (± 0.7) μm (n= 18 axons from
three separate experiments)
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separate experiments), although some healthy, polarized
mitochondria were blocked by damaged fragments, the
majority by-passed these “road blocks” to travel onward to
the distal axon (annotated by asterisks in Fig. 4). There
was a statistically significant difference between the cali-
bers of the axons that were differentially affected by laser
photo-toxicity (p < 0.001, Student’s t test).
Discussion
Clinical and pathological studies implicate dysfunction of
small-diameter fibers in the early neurological signs of the
most common form of acute peripheral inflammatory poly-
radiculoneuropathy, Guillain-Barré syndrome (GBS). In this
study, we reveal how inflammation within the saphenous
nerve is associated with mitochondrial dysfunction in
small-diameter fibers, in vivo. The effects involve a sequen-
tial process including (i) loss of mitochondrial membrane
potential followed by mitochondrial fragmentation, (ii) ac-
cumulation of mitochondrial debris at the site of damage,
(iii) compensatory increase in anterograde mitochondrial
transport proximal to the site of damage, (iv) obstruction of
incoming transported mitochondria by the debris, and (v)
mitochondrial depletion distal to the site of initial damage.
We show that the consequences of this sequence of events
are different in small-diameter myelinated axons compared
with medium- and large-diameter axons in that greater
mitochondrial density and space restrictions render small-
caliber axons becoming more susceptible to a complete
block of axonal transport of mitochondria at the site of ini-
tial mitochondrial damage.
Association between inflammation and mitochondrial
damage
At the onset of the signs of EAN, we observed that some
axonal mitochondria appeared fragmented and depolar-
ized, and that these were always associated with immo-
bile inflammatory cells that were closely juxtaposed to
the axon concerned. It was not clear whether the inflam-
matory cells were attracted by signals from the damaged
axon, or whether the mitochondrial damage was a con-
sequence of the attachment of the inflammatory cell to
the axon as a consequence of the anti-nerve immune re-
sponse, but it seems reasonable to speculate that in this
model of active immunization, it was the inflammatory
cells that were the instigators of the damage. Indeed, we
have not observed mitochondrial damage or disruption
of mitochondrial transport in any of the control groups
of animals, i.e., animals that received only adjuvants,
pyrogenic doses of LPS i.p., or application of in vitro-
activated macrophages. Early mitochondrial damage in
the context of neuroinflammation has been documented
in EAE [17, 18], as well as in MS [19, 20], where soluble
inflammatory mediators and reactive oxygen species
have been implicated.
Consequences of focal mitochondrial damage for the axons
The likely consequences of loss of functional mitochon-
dria to the affected axon are multiple and complex. One
of the most obvious is an energy crisis, with resulting
Ca2+ toxicity due to depletion of the ATP required for
Ca2+ homeostasis and the release of Ca2+ from damaged
mitochondria [21]. It is well established that both a lack
of ATP and high Ca2+ concentration are incompatible
with long-term axonal survival [22, 23]. Thus, unsurpris-
ingly, an increase in ADP [24] and Ca2+ have both been
implicated in regulating mitochondrial axonal transport
towards the area of high energy demand [25]. Such regu-
lated, directional transport of functional mitochondria is
vital for axonal survival under different physiological
[26] and pathological conditions [21, 27, 28]. In agree-
ment with these observations, made in ex vivo models,
is our finding that focal, photo-toxic damage of axonal
mitochondria rapidly induces an increase in anterograde
transport of functional mitochondria towards the site of
damage, in vivo. The supply of these mitochondria to
the affected area would provide the ATP necessary to
handle excess Ca2+, preventing axonal dysfunction, and
possibly degeneration.
However, another challenge for axons affected by focal
mitochondrial damage is the effective disposal of mito-
chondrial debris. In vitro studies have indicated that
damaged axonal mitochondria are transported retro-
gradely to the cell body in order to be degraded [29]. It
was later observed, in cultured hippocampal neurons,
that autophagosome formation and subsequent mito-
phagy may occur without additional transport of dam-
aged mitochondria, i.e., in situ [30]. Indeed, our study
shows that in long, adult axons in vivo, damaged mito-
chondria are not removed from the site of damage and
transported elsewhere for at least 3 h following the ini-
tial damage. The advantage of the in situ degradation of
mitochondria is rapid neuroprotection against oxidative
damage without energetically expensive and lengthy
retrograde axonal transport [31]. Indeed, the mechanism
underlying the detachment of depolarized mitochondria
from microtubules, thereby preventing further axonal
transport, has been described in rat hippocampal cul-
tures. Namely, depolarized mitochondria are targeted by
the PINK1/Parkin pathway, which subsequently initiates
proteasome-dependent degradation of the mitochondrial
adaptor protein Miro, resulting in release of the motor
protein kinesin from mitochondrial surface [32]. Once
detached from kinesin, depolarized mitochondria be-
come arrested and likely stabilized in situ by cytoskeletal
neurofilament [33].
An important finding of our study is that the presence
of mitochondrial debris, exacerbated by a compensatory
increase in axonal transport of functional mitochondria,
represents a challenge for axons, especially myelinated
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axons of small caliber. It should be noted that by small--
caliber axons, we do not refer to the classical nocicep-
tors, the unmyelinated (or C) fibers, although a
proportion of these axons is strongly, specifically labeled
with IB4. Indeed, we have used another characteristic of
IB4 to faintly label myelin, in order to visualize and
measure the caliber of the small-caliber myelinated
axons. By using this method, the caliber of any myelin-
ated axon can be precisely measured, for example using
the ZEN imaging software. The increased influx of func-
tional mitochondria mentioned above is likely designed
to improve the bio-energetic profile of the affected area
of the axon; its spatial co-localization with the stationary
mitochondrial debris may be counterproductive. Namely,
the accumulated mitochondrial debris in small-diameter
axons seems physically to obstruct the passage of the in-
coming, functional mitochondria from reaching parts of
the axon distal to the affected site. In a similar way, a car
breakdown on a small road will obstruct passing cars
causing a traffic jam, whereas the same car on a wide road
will have little consequence. Similarly, in medium- and
large-caliber axons, the functional mitochondria can by-
pass damaged mitochondria. Thus, it appears that the co-
incidence of damaged mitochondria and a compensatory
increase in axonal transport of functional mitochondria
represents a challenge axons for small caliber. Indeed, we
have shown that mitochondrial density is greater in the
small-caliber axons than in the larger ones, which exacer-
bates the problem.
Further to the accumulation of mitochondrial debris,
the damage to mitochondria within the axons will acti-
vate mechanisms for removal of such debris, for example
via activation of PINK1/Parkin pathway, as mentioned
above. The consequence of activation of PINK1/Parkin
pathway is the formation of autophagosomes. Our and
other recent studies strongly suggest that such forma-
tions will form locally, and this will further increase the
mass of heterogeneous material likely to obstruct trans-
port in small-caliber axons. It is easy to envisage the for-
mation of a vicious circle aggravating transport deficits
following an inflammatory insult and reducing the possi-
bility of recovery. This consideration highlights the op-
portunities that may arise from enhancing the removal
of debris material, such as improved mitophagy and au-
tophagy strategies, in neurodegenerative diseases. In-
deed, the distal segments of the affected small-diameter
axons had already become depleted of functional mito-
chondria upon first observation, and this problem got
worse during our observation period. Therefore, in vivo,
only a few hours may be a sufficient time period for the
consequences of blocked axonal transport and metabolic
disturbances to become exacerbated. The depletion of
mitochondria in the distal axon is likely to contribute to
the long-term dysfunction and distal degeneration
resulting from inflammatory insult. Indeed, sensory im-
pairment remains a long-term consequence of GBS [10,
11], and it correlates with the density of intra-epidermal
nerve fibers (IENF) [34], suggesting that the dysfunction
is progressive, finally resulting in degeneration of the
distal axon.
It seems likely that mitochondrial damage and distal
depletion of mitochondria precipitated by selective ob-
struction of small-diameter myelinated axons could play
a part in a number of other inflammatory conditions
characterized by small fiber degeneration. Indeed, it has
been shown in cultured dorsal root ganglia expressing
small fiber neuropathy-associated G856D mutant Nav1.7
channels that degeneration of neurites [35] is promoted
by a decrease in ATP levels and increase in intracellular
calcium levels [Ca2+]i, which would be expected as a
consequence of mitochondrial damage and depletion.
Selective loss of small-diameter myelinated axons occurs
in CNS in multiple sclerosis [36], and it is especially
prominent in small fiber neuropathies (SFN), which are
often characterized by pain and autonomic symptoms,
including diabetic neuropathy [37–39], chemotherapy-
associated neuropathy [40], HIV [41], systemic lupus
erythematosus [42], paraneoplastic syndrome [43], sar-
coidosis [44], drug toxicity [45–47], hereditary neuropa-
thies [48], familial amyloidosis [49], and inflammatory
peripheral neuropathy and Guillain-Barré syndrome
(GBS) [42]. The pervasive vulnerability of small-diameter
axons is striking, and the mechanisms described in this
paper may contribute to their selective vulnerability. If so,
research into therapeutic strategies to overcome the for-
mation of a mitochondrial plug, such as stimulating the
degradation of mitochondrial debris, may be beneficial
target for treating peripheral neuropathies.
Conclusion
The inflammatory insult creates debris of stationary,
damaged mitochondria within axons. In small-diameter
myelinated axons, the combination of a space restriction
and a high density of mitochondrial debris together re-
sult in plugging of axons with debris which in turn fur-
ther obstructs axonal transport and hinders repopulation
of the affected segments with healthy mitochondria. The
long-term depletion of mitochondria from affected
portion and distal axons may contribute to the meta-
bolic impairment, long-term dysfunction, and distal
axonal degeneration.
Methods
Animals
All animal experiments were carried out according to
the 1986 Animals (Scientific Procedures) Act, UK, and
were approved by the institutional ethics committee.
Mice used in this study were male, 8–12 weeks old, and
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either Thy1-CFP-S-positive or Thy1-CFP-S-negative lit-
termates (Jackson laboratories strain designation: B6;CB-
Tg (Thy1-CFP/COX8A)S2Lich/J). In CFP-S mice, the
cyan fluorescent protein is constitutively expressed only
in axonal mitochondria, affecting approximately 40–60%
of them, and thus, the label was used to distinguish
axonal from Schwann (and other) cell mitochondria. As
the CFP labeled mitochondria fluoresce blue regardless
of their membrane potential, we used another probe tet-
ramethylrhodamine methyl ester (TMRM, Invitrogen,
UK) which partitions into polarized mitochondria to label
polarized (probably healthy) mitochondria selectively.
Induction and assessment of experimental autoimmune
neuritis (EAN)
EAN was induced in 8–12-week-old Thy1-CFP-S-posi-
tive and Thy1-CFP-S-negative littermates (Jackson
laboratories strain designation: B6;CB-Tg(Thy1-CFP/
COX8A)S2Lich/J) by two subcutaneous injections, 6 days
apart, of an emulsion prepared from saline solutions of
peripheral bovine myelin (2.5 mg/mouse), P0106–125
(50 μg/mouse) (Genosphere Biotechnologies, Paris,
France) and P251–84 (50 μg/mouse) (a kind gift from Dr.
Norman A Gregson) and incomplete Freund’s adjuvant
(Sigma, Poole, UK) supplemented with 0.5 mg of heat-
inactivated Mycobacterium tuberculosis (Difco, USA).
The injections were carried out under isoflurane
anesthesia (2% in oxygen). In addition, 200 ng of pertus-
sis toxin (Chemicon, UK) was administered intraperito-
neally to each mouse, both at the same time as the first
immunization and also 1 day later. At the same time,
control mice received the same amount of emulsion pre-
pared from saline and the same doses of adjuvants.
Animals were daily weighed and assessed for disease se-
verity using a 10-point scale, one point being given for
each of the following signs: reduction of muscle tone of
tail tip, reduction of muscle tone of the whole tail, tail
paralysis, inability to spread toes, unsteady gait, hind
limb paresis (one point per limb), limb paralysis (one
point per limb), and moribund. The cumulative severity
of motor deficit that each animal exhibited was
expressed as the area under the curve of that animal’s
motor deficit against time, as calculated using GraphPad
Prism software.
Surgical procedure and imaging
On the first day of appearance of neurological signs of
EAN (symptomatic EAN group), typically week tip of
the tail, mice were anesthetized (no recovery; urethane;
1.25 g/kg) for imaging studies, as previously described
[26]. On the same day, or a day after, an adjuvant-only
control mouse was examined in the same way. Briefly,
the skin was opened under urethane anesthesia at the
thigh and the connective tissue carefully removed.
Approximately 1 cm of the left saphenous nerve was ex-
posed in the middle of the thigh, and desheathed taking
care to avoid any damage to the nerve fibers or the vas-
culature. The nerve was incubated in situ with tetra-
methylrhodamine methyl ester (TMRM; 0.5 μM solution
in sterile saline; pH = 7.4) for 45 min, followed by
Griffonia IB4 (Sigma, UK, 1:20 in sterile saline) for
10 min. Labelling with TMRM in these mice enabled
distinguishing between two populations of mitochondria,
polarized (healthy) and depolarized (damaged). Thus, as
a potentiometric, kationic dye, TMRM accumulates only
in mitochondria with preserved membrane potential.
Thus, TMRM+ CFP+ mitochondria are considered healthy
and in confocal images appear pale pink or white. In con-
trast, CFP is constitutively expressed in all axonal mito-
chondria regardless of their membrane potential; thus,
TMRM−, CFP+ mitochondria are depolarized and are con-
sidered damaged (in confocal images, they appear cyan).
Following the labelling, the animal was transferred to the
customized stage of a confocal microscope (LSM Pascal
5.0, Zeiss, Germany). Time-lapse or single images of the
middle portion of the exposed nerve in the thigh were ac-
quired at 1.97 s per frame using LSM Pascal 5.0 software
(Zeiss, Germany) and Zeiss Apochromat Plan × 63 (oil)
warmed (36 °C) objective (NA 1.4). The rectal temperature
was continuously monitored and maintained at 36 °C by an
underlying heating mat. In total, a minimum of three ani-
mals from each group were examined.
Focal, photo-toxic damage of axonal mitochondria in vivo
An additional three asymptomatic EAN animals were
used to study the effects of photo-toxic damage to
axonal mitochondria, in vivo. The saphenous nerve was
surgically prepared and labeled with TMRM and IB4, as
described above. Three adjacent regions, each measuring
124 μm2 (corresponding the field of view under × 63 ob-
jective), were identified along the saphenous nerve
(Fig. 3). In order to determine the baseline rate of mito-
chondrial transport within those regions, time-lapse im-
ages of axonal mitochondria were taken as described
above. Next, the central of the three regions was photo-
bleached by repeated scanning using laser light at
561 nm. The process was repeated until TMRM was en-
tirely photo-bleached. After photo-bleaching, time-lapse
images were taken again in the same three regions, i.e.,
the central, and proximal and distal to central, in order
to evaluate mitochondrial function and transport in the
same axons as before the photo-toxic damage.
Image analysis
The number, direction, velocity of moving, and the size
of axonal mitochondria in the time-lapse videos were
analyzed by a blinded examiner using ImageJ. As CFP is
present in both healthy and damaged mitochondria,
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these measurements were performed on the red channel
(i.e., the TMRM labelling) to exclude damaged mito-
chondria from skewing the analyses of mitochondrial
transport. However, the CFP labelling was used to con-
firm that the analyzed particles were indeed axonal, and
not Schwann cell, mitochondria. Also, mitochondrial
length in axons was determined in both channels, separ-
ately. Internodal segments of myelinated axons with cali-
ber between 4 and 7 μm were first straightened using
the Straighten plug-in (http://rsbweb.nih.gov/ij/plugins/
straighten.html) for ImageJ version 1.43 software (NIH,
Bethesda, MD, USA, rsb.info.nih.gov/ij/). Straightened
axons were processed using the Difference Tracker plug-
in (https://www.bioinformatics.babraham.ac.uk/projects/
difference_tracker/) for ImageJ as previously described
[50, 51], and fluorescent particles with a lower cutoff of
5 pixels moving for at least six consecutive frames were
considered to be moving mitochondria. The lower cutoff
was determined by examination of the size of the smallest
moving CFP and TMRM+ particles. The number of mov-
ing mitochondria and their direction and velocity were
directly derived from the results table generated by the
Mass Particle Tracker component of the Difference
Tracker plug-in. Length of stationary mitochondria was
analyzed using the ImageJ Analyse Particle plug-in. First,
time-lapse images of axons were straightened using the
Straighten plug-in, the background was reduced using in-
tensity subtraction (the radius of the rolling ball was set to
5) in ImageJ, and the time lapse was converted into a bin-
ary form. Using the drawing tool, all the moving particles
were eliminated. The dimensions of the remaining station-
ary particles were analyzed using the Analyse Particle
plug-in for ImageJ, whereby the Feret’s diameter value was
converted into length in micrometers.
Data analysis
Prior to all statistical analyses, the data were tested for
normality of distribution using the D’Agostino and
Pearson normality test. To calculate differences between
the number of track counts and the velocity of mito-
chondrial transport in different groups of animals, non-
parametric one-way ANOVA with Dunn’s multiple
comparison post-test was used. However, to calculate
the difference between the number of mobile mitochon-
dria before and after laser photo-toxic damage, we used
repeated measures ANOVA. Differences in length of
mitochondria are tense change calculated using one-way
ANOVA with Dunn’s multiple comparison tests. Differ-
ences between the numbers of small-diameter axons
with detected accumulations in different groups were
calculated using Student’s t test. Parametric data are
presented as mean ± SEM, whereas non-parametric, or
data which did not follow a normal distribution, are
presented as median ± interquartile range (IQR).
Additional files
Additional file 1: Video S1. High-power time-lapse video of inflamed
saphenous nerve on the first day of onset of EAN taken immediately upon
exposing the saphenous nerve. Axonal myelin (clearly visible around node
of Ranvier) is labeled with IB4+ (green) and functional mitochondria are
labeled with TMRM (red). Some of the axonal mitochondria are mobile. In
between axons, a number of infiltrating inflammatory cells labeled with IB4+
(surface label, green arrows) can be seen, including the mitochondria
(TMRM, red) within the cells. Most inflammatory cells appear freely
mobile and moving in typical amoeboid fashion between the axons.
In one axon (white arrowhead), functional mitochondria appear focally
accumulated, as opposed to uniformly distributed mitochondrial in
surrounding axons. One of the inflammatory cells, encircled, can be
seen juxtaposed to this focal accumulation. (AVI 3211 kb)
Additional file 2: Video S2. High-power time-lapse video of inflamed
saphenous nerve on the first day of onset of EAN, taken 40 min after the
exposure of saphenous nerve. Forty minutes following the first time-lapse
video (Additional file 1: Video S1), the same axons are apparent in the
field of view. Some mobile inflammatory cells (surface labeled with IB4+,
green) and functional mitochondria (TMRM, red) can be seen. Notably,
one inflammatory cell (encircled) can be seen closely juxtaposed to the
same axon as seen 40 min earlier, still stationary. This is likely to be the
same cell, remaining in the close proximity to the axon throughout the
40-min period. The accumulation of axonal mitochondria within this axon
appear extended, with some loss of bright red TMRM labelling (mitochondrial
membrane potential), suggesting possible mitochondrial damage in that area.
(AVI 2879 kb)
Additional file 3: Video S3. High-power time-lapse video of axonal
mitochondria labeled with TMRM on the day of onset of EAN taken
immediately upon exposing the saphenous nerve. Focal accumulation
of functional axonal mitochondria (yellow arrow) is observed, with
mitochondria moving in anterograde direction. Distal to the accumulation,
axons appear depleted of functional mitochondria. In contrast, mitochondrial
distribution and morphology appears normal in another axon (green arrow) which
is of larger caliber than the two axons affected by mitochondrial accumulation.
The video is shown in gray scale in order to improve contrast. (AVI 3253 kb)
Additional file 4: Video S4. High-power time-lapse video of axonal
mitochondria labeled with TMRM on the day of onset of EAN taken
80 min upon exposing the saphenous nerve. Eighty minutes following the
Additional file 3: Video S3, the focal accumulations of functional axonal
mitochondria (yellow arrow) appear enlarged in comparison with the
earlier time point. Anterograde mitochondrial movement in these axons
seems unaffected. Notably, in an axon positioned between the two axons
with accumulations (green arrow) and which is of larger diameter than the
two indicated with yellow arrows, mitochondrial distribution and morphology
appear normal. The video is shown in gray scale in order to improve contrast.
(AVI 1353 kb)
Additional file 5: Video S5. High-power time-lapse video of axonal
mitochondria labeled with TMRM immediately following laser-induced
phototoxic damage to mitochondria. The side of the imaging field
left to the white line was not exposed to photo-toxic damage. The
imaging field to the right of the white line was exposed to laser-induced
photo-toxic damage, using the red laser to specifically damage functional
mitochondria. Notably, the number of mobile mitochondria transported into
the area exposed to photo-toxic damage appears overwhelmingly biased in
the favor of anterograde movement. (AVI 2466 kb)
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